Advertisement
U.S. markets open in 4 hours 17 minutes

Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
34.19+1.21 (+3.67%)
At close: 04:00PM EDT
34.19 0.00 (0.00%)
After hours: 04:02PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
1.87B1.58B1.51B1.64B1.97B1.93B
Enterprise Value
1.66B1.42B1.40B1.94B1.96B1.98B
Trailing P/E
1.71k68.4936.2833.4034.8454.05
Forward P/E
20.16N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
3.132.712.632.793.353.24
Price/Book (mrq)
2.031.741.641.802.232.27
Enterprise Value/Revenue
2.738.669.0714.2912.7311.84
Enterprise Value/EBITDA
18.4462.7943.96429.7862.8834.40

Trading Information

Stock Price History

Beta (5Y Monthly) 0.97
52-Week Change 3-6.84%
S&P500 52-Week Change 328.64%
52 Week High 339.09
52 Week Low 321.99
50-Day Moving Average 329.20
200-Day Moving Average 329.12

Share Statistics

Avg Vol (3 month) 3363.69k
Avg Vol (10 day) 3462.91k
Shares Outstanding 554.73M
Implied Shares Outstanding 654.73M
Float 847.71M
% Held by Insiders 15.12%
% Held by Institutions 1107.86%
Shares Short (Feb 29, 2024) 44.41M
Short Ratio (Feb 29, 2024) 412.68
Short % of Float (Feb 29, 2024) 412.13%
Short % of Shares Outstanding (Feb 29, 2024) 48.05%
Shares Short (prior month Jan 31, 2024) 43.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.22%
Operating Margin (ttm)11.56%

Management Effectiveness

Return on Assets (ttm)0.56%
Return on Equity (ttm)0.15%

Income Statement

Revenue (ttm)607.52M
Revenue Per Share (ttm)11.14
Quarterly Revenue Growth (yoy)-1.80%
Gross Profit (ttm)N/A
EBITDA 98.26M
Net Income Avi to Common (ttm)1.32M
Diluted EPS (ttm)0.02
Quarterly Earnings Growth (yoy)-95.40%

Balance Sheet

Total Cash (mrq)254.87M
Total Cash Per Share (mrq)4.66
Total Debt (mrq)41.53M
Total Debt/Equity (mrq)4.51%
Current Ratio (mrq)1.70
Book Value Per Share (mrq)16.84

Cash Flow Statement

Operating Cash Flow (ttm)111.08M
Levered Free Cash Flow (ttm)161.71M